A total of 205 adult women (mean age, 52.7 years) with diabetic gastroparesis and delayed gastric emptying were randomly allocated (1:1) to placebo or MNS administered in either nostril, four times ...

Evoke Pharma submitted a new drug application to the FDA for its acute and recurrent diabetic gastroparesis nasal spray Gimoti. The spray relieves symptoms in adult women. 1. Acute and recurrent ...

Evoke Pharma, Inc. announced that it has received a Notice of Allowance from the USPTO for a patent application covering the use of its GIMOTI® (metoclopramide) nasal spray in patients with moderate ...

High blood sugar can slow down your stomach, causing stomach pain. About 20% to 50% of people with diabetes will experience diabetic gastroparesis. Symptoms of diabetic gastroparesis include feeling ...

CinDome Pharma, a CinRx portfolio company dedicated to advancing a safe, chronic therapy for gastroparesis, today announced that it has completed enrollment in the envision3D Phase 2 clinical trial of ...

Credit: Getty Images As more reports surface about gastroparesis developing in patients who receive treatment with semaglutide, what should clinicians keep in mind? Semaglutide-containing medications ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing significant statistical improvement for GIMOTI over Oral Metoclopramide in All ...

A rising number of Ozempic gastroparesis lawsuits are being filed across the United States, alleging that the popular diabetes and weight-loss drug has caused patients to develop severe stomach ...

Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Eating small frequent meals is among the dietary strategies that could improve gastric emptying. Recommendations include eating small frequent meals, chewing foods well, and limiting insoluble fiber.